PortfoliosLab logoPortfoliosLab logo
NWBO vs. AWI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NWBO vs. AWI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Northwest Biotherapeutics, Inc. (NWBO) and Armstrong World Industries, Inc. (AWI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NWBO achieves a -21.18% return, which is significantly lower than AWI's -18.20% return. Over the past 10 years, NWBO has underperformed AWI with an annualized return of -9.70%, while AWI has yielded a comparatively higher 15.87% annualized return.


NWBO

1D
1.29%
1M
-10.07%
6M
-33.22%
YTD
-21.18%
1Y
-20.75%
3Y*
-31.34%
5Y*
-32.74%
10Y*
-9.70%

AWI

1D
0.12%
1M
0.96%
6M
-21.21%
YTD
-18.20%
1Y
-6.66%
3Y*
29.36%
5Y*
8.91%
10Y*
15.87%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NWBO vs. AWI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NWBO
Northwest Biotherapeutics, Inc.
-21.18%-16.74%-60.81%-10.64%12.07%-54.10%626.19%2.19%-14.38%-31.05%
AWI
Armstrong World Industries, Inc.
-18.20%36.23%45.05%45.37%-40.26%57.44%-19.97%62.79%-3.61%44.86%

Correlation

The correlation between NWBO and AWI is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.02

Correlation (All Time)
Calculated using the full available price history since Oct 18, 2006

0.05

The correlation between NWBO and AWI shifts across timeframes, from -0.07 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NWBO:

$296.29M

AWI:

$6.64B

EPS

NWBO:

-$0.06

AWI:

$7.05

PS Ratio

NWBO:

287.11

AWI:

4.11

Total Revenue (TTM)

NWBO:

$937.00K

AWI:

$1.65B

Gross Profit (TTM)

NWBO:

$416.00K

AWI:

$664.10M

EBITDA (TTM)

NWBO:

-$79.62M

AWI:

$578.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NWBO vs. AWI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NWBO
NWBO Risk / Return Rank: 3131
Overall Rank
NWBO Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
NWBO Sortino Ratio Rank: 3333
Sortino Ratio Rank
NWBO Omega Ratio Rank: 3333
Omega Ratio Rank
NWBO Calmar Ratio Rank: 2828
Calmar Ratio Rank
NWBO Martin Ratio Rank: 2828
Martin Ratio Rank

AWI
AWI Risk / Return Rank: 3333
Overall Rank
AWI Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
AWI Sortino Ratio Rank: 3030
Sortino Ratio Rank
AWI Omega Ratio Rank: 3030
Omega Ratio Rank
AWI Calmar Ratio Rank: 3636
Calmar Ratio Rank
AWI Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NWBO vs. AWI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Northwest Biotherapeutics, Inc. (NWBO) and Armstrong World Industries, Inc. (AWI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NWBOAWIDifference
Sharpe ratioReturn per unit of total volatility

-0.05

Sortino ratioReturn per unit of downside risk

+0.15

Omega ratioGain probability vs. loss probability

1.00

0.98

+0.02

Calmar ratioReturn relative to maximum drawdown

-0.47

-0.27

-0.20

Martin ratioReturn relative to average drawdown

-0.82

-0.53

-0.29

NWBO vs. AWI - Sharpe Ratio Comparison

The current NWBO Sharpe Ratio is -0.31, which is comparable to the AWI Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of NWBO and AWI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NWBO vs. AWI - Drawdown Comparison

The maximum NWBO drawdown since its inception was -99.99%, which is greater than AWI's maximum drawdown of -80.98%. Use the drawdown chart below to compare losses from any high point for NWBO and AWI.


Loading charts...

Drawdown Indicators


NWBOAWIDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-80.98%

-19.01%

Max Drawdown (1Y)

Largest decline over 1 year

-44.42%

-24.98%

-19.44%

Max Drawdown (3Y)

Largest decline over 3 years

-82.90%

-24.98%

-57.92%

Max Drawdown (5Y)

Largest decline over 5 years

-90.69%

-46.06%

-44.63%

Max Drawdown (10Y)

Largest decline over 10 years

-92.27%

-46.44%

-45.83%

Current Drawdown

Current decline from peak

-99.99%

-23.12%

-76.87%

Average Drawdown

Average peak-to-trough decline

-97.15%

-18.27%

-78.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.39%

12.68%

+12.71%

Volatility

NWBO vs. AWI - Volatility Comparison

Northwest Biotherapeutics, Inc. (NWBO) has a higher volatility of 12.87% compared to Armstrong World Industries, Inc. (AWI) at 7.37%. This indicates that NWBO's price experiences larger fluctuations and is considered to be riskier than AWI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NWBOAWIDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.87%

7.37%

+5.50%

Volatility (6M)

Calculated over the trailing 6-month period

36.76%

20.54%

+16.22%

Volatility (1Y)

Calculated over the trailing 1-year period

67.35%

26.23%

+41.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

81.97%

26.29%

+55.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.57%

29.86%

+62.71%

Dividends

NWBO vs. AWI - Dividend Comparison

NWBO has not paid dividends to shareholders, while AWI's dividend yield for the trailing twelve months is around 0.85%.


PositionTTM20252024202320222021202020192018
AWI
Armstrong World Industries, Inc.
0.85%0.66%0.81%1.06%1.38%0.74%1.09%0.77%0.30%
NWBO
Northwest Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

NWBO vs. AWI - Financials Comparison

This section allows you to compare key financial metrics between Northwest Biotherapeutics, Inc. and Armstrong World Industries, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
200.00K
409.90M
(NWBO) Total Revenue
(AWI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NWBO and AWI have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NWBO has higher volatility (12.87%) compared to AWI (7.37%). In terms of maximum drawdown, NWBO dropped -99.99% vs AWI's -80.98%.

AWI currently has the higher Sharpe Ratio (-0.26 vs -0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NWBO and AWI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer